1. Home
  2. ENSC vs MTR Comparison

ENSC vs MTR Comparison

Compare ENSC & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • MTR
  • Stock Information
  • Founded
  • ENSC 2003
  • MTR 1979
  • Country
  • ENSC United States
  • MTR United States
  • Employees
  • ENSC 8
  • MTR N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • MTR Oil & Gas Production
  • Sector
  • ENSC Health Care
  • MTR Energy
  • Exchange
  • ENSC Nasdaq
  • MTR Nasdaq
  • Market Cap
  • ENSC 9.5M
  • MTR 11.8M
  • IPO Year
  • ENSC N/A
  • MTR N/A
  • Fundamental
  • Price
  • ENSC $0.69
  • MTR $5.88
  • Analyst Decision
  • ENSC
  • MTR
  • Analyst Count
  • ENSC 0
  • MTR 0
  • Target Price
  • ENSC N/A
  • MTR N/A
  • AVG Volume (30 Days)
  • ENSC 83.4M
  • MTR 8.1K
  • Earning Date
  • ENSC 11-12-2024
  • MTR 01-01-0001
  • Dividend Yield
  • ENSC N/A
  • MTR 4.87%
  • EPS Growth
  • ENSC N/A
  • MTR N/A
  • EPS
  • ENSC N/A
  • MTR 0.47
  • Revenue
  • ENSC $4,421,404.00
  • MTR $1,248,772.00
  • Revenue This Year
  • ENSC N/A
  • MTR N/A
  • Revenue Next Year
  • ENSC N/A
  • MTR N/A
  • P/E Ratio
  • ENSC N/A
  • MTR $12.54
  • Revenue Growth
  • ENSC 40.41
  • MTR N/A
  • 52 Week Low
  • ENSC $0.14
  • MTR $5.60
  • 52 Week High
  • ENSC $2.06
  • MTR $18.92
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 61.12
  • MTR 43.23
  • Support Level
  • ENSC $0.62
  • MTR $5.90
  • Resistance Level
  • ENSC $0.81
  • MTR $6.31
  • Average True Range (ATR)
  • ENSC 0.15
  • MTR 0.27
  • MACD
  • ENSC 0.01
  • MTR -0.01
  • Stochastic Oscillator
  • ENSC 53.71
  • MTR 10.13

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About MTR Mesa Royalty Trust

Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.

Share on Social Networks: